[go: up one dir, main page]

NO20000330D0 - Fremgangsmåte ved fremstilling av farmasoeytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein - Google Patents

Fremgangsmåte ved fremstilling av farmasoeytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein

Info

Publication number
NO20000330D0
NO20000330D0 NO20000330A NO20000330A NO20000330D0 NO 20000330 D0 NO20000330 D0 NO 20000330D0 NO 20000330 A NO20000330 A NO 20000330A NO 20000330 A NO20000330 A NO 20000330A NO 20000330 D0 NO20000330 D0 NO 20000330D0
Authority
NO
Norway
Prior art keywords
lipid
protein
preparation
articles
pharmaceutical compositions
Prior art date
Application number
NO20000330A
Other languages
English (en)
Other versions
NO20000330L (no
Inventor
Matthias Andersson
Dorota Johansson
Percy Li
Bjoern Norrlind
Bengt Westgren
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of NO20000330D0 publication Critical patent/NO20000330D0/no
Publication of NO20000330L publication Critical patent/NO20000330L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1275—Lipoproteins or protein-free species thereof, e.g. chylomicrons; Artificial high-density lipoproteins [HDL], low-density lipoproteins [LDL] or very-low-density lipoproteins [VLDL]; Precursors thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20000330A 1997-07-22 2000-01-21 FremgangsmÕte ved fremstilling av farmasøytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein NO20000330L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702776A SE9702776D0 (sv) 1997-07-22 1997-07-22 Method of preparing pharmaceutical compositions
PCT/SE1998/001407 WO1999004761A1 (en) 1997-07-22 1998-07-22 Method of preparing pharmaceutical compositions of lipid particles comprising a lipid agent and a protein

Publications (2)

Publication Number Publication Date
NO20000330D0 true NO20000330D0 (no) 2000-01-21
NO20000330L NO20000330L (no) 2000-03-21

Family

ID=20407807

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000330A NO20000330L (no) 1997-07-22 2000-01-21 FremgangsmÕte ved fremstilling av farmasøytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein

Country Status (12)

Country Link
EP (1) EP1014947B1 (no)
JP (1) JP3813439B2 (no)
AT (1) ATE289806T1 (no)
AU (1) AU744738B2 (no)
CA (1) CA2297924C (no)
DE (1) DE69829191T2 (no)
ES (1) ES2236919T3 (no)
NO (1) NO20000330L (no)
NZ (1) NZ502840A (no)
PT (1) PT1014947E (no)
SE (1) SE9702776D0 (no)
WO (1) WO1999004761A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1574210B1 (en) * 1999-02-26 2016-04-06 Novartis Vaccines and Diagnostics, Inc. Microemulsions with adsorbed macromolecules
CA2364939A1 (en) * 1999-12-22 2001-06-28 Surgical Sealants, Inc. Methods and compositions for sealing tissue leaks
HUP0200750A3 (en) * 2000-02-02 2005-02-28 Univ Florida State Res Found C10 heterosubstituted acetate taxanes as antitumor agents and pharmaceutical compositions containing them and their use
US6514523B1 (en) * 2000-02-14 2003-02-04 Ottawa Heart Institute Research Corporation Carrier particles for drug delivery and process for preparation
AU2001257115B2 (en) * 2000-04-20 2005-01-27 Rtp Pharma Inc. Improved water-insoluble drug particle process
US6599441B1 (en) * 2000-07-18 2003-07-29 Emerald Biostructures, Inc. Crystallization solutions
US7803400B2 (en) 2002-12-03 2010-09-28 Blanchette Rockefeller Neurosciences Institute Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
CN101284136A (zh) 2002-12-03 2008-10-15 布朗歇特洛克菲勒神经科学研究所 传输物质穿过血脑屏障的人工低密度脂蛋白载体
PL1613346T3 (pl) * 2003-04-04 2013-03-29 Zoetis Services Llc Poddane mikrofluidyzacji emulsje typu olej w wodzie i kompozycje szczepionek
WO2006082824A1 (ja) * 2005-02-03 2006-08-10 Nrl Pharma, Inc. マトリックス型腸溶性・徐放性組成物
KR100902570B1 (ko) * 2005-03-28 2009-06-11 주식회사 리제론 단백질을 포위하는 나노리포좀의 제조방법 및 단백질-포위나노리포좀
EP1979410B1 (en) * 2005-12-29 2012-08-22 Life Technologies Corporation Compositions and methods for improving resolution of biomolecules separated on polyacrylamide gels
EP1915986A1 (en) 2006-10-23 2008-04-30 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Lipid growth factor formulations
CH715456B1 (de) 2007-04-27 2020-04-30 Mibelle Ag Kosmetisches Produkt zur topischen Anwendung für den Schutz und die Erneuerung von Hautstammzellen, welches sich von dedifferenzierten Pflanzenzellen ableitet.
US8071759B2 (en) 2008-07-18 2011-12-06 Affymetrix, Inc. Water soluble cholesterol derivatives
CA2780482A1 (en) 2008-11-17 2010-05-10 Anil K. Sood Hdl particles for delivery of nucleic acids
DK2474306T3 (en) 2009-08-31 2017-02-06 Nanocarrier Co Ltd PARTICLE COMPOSITION AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
US9763892B2 (en) 2015-06-01 2017-09-19 Autotelic Llc Immediate release phospholipid-coated therapeutic agent nanoparticles and related methods
WO2025215934A1 (ja) * 2024-04-09 2025-10-16 コニカミノルタ株式会社 予測装置、予測装置の粒径分布予測方法、および粒径分布予測プログラム

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128318A (en) * 1987-05-20 1992-07-07 The Rogosin Institute Reconstituted HDL particles and uses thereof
IL86799A (en) * 1987-07-02 1993-03-15 Kabi Pharmacia Ab Method and device for injection
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5652339A (en) * 1993-12-31 1997-07-29 Rotkreuzstiftung Zentrallaboratorium Method of producing reconstituted lipoproteins

Also Published As

Publication number Publication date
CA2297924A1 (en) 1999-02-04
SE9702776D0 (sv) 1997-07-22
EP1014947A1 (en) 2000-07-05
PT1014947E (pt) 2005-05-31
JP2001510786A (ja) 2001-08-07
AU744738B2 (en) 2002-02-28
JP3813439B2 (ja) 2006-08-23
AU8371898A (en) 1999-02-16
ATE289806T1 (de) 2005-03-15
CA2297924C (en) 2007-04-10
DE69829191D1 (de) 2005-04-07
EP1014947B1 (en) 2005-03-02
ES2236919T3 (es) 2005-07-16
WO1999004761A1 (en) 1999-02-04
DE69829191T2 (de) 2005-07-21
NZ502840A (en) 2002-08-28
NO20000330L (no) 2000-03-21

Similar Documents

Publication Publication Date Title
NO20000330D0 (no) Fremgangsmåte ved fremstilling av farmasoeytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein
CZ58196A3 (en) Naphthyl derivative, process of its preparation, pharmaceutical composition containing and intermediate for preparing thereof
AU649973B2 (en) Aromatic amine compounds, their method of preparation and pharmaceutical compositions in which they are present
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
ATE34078T1 (de) Arzneiform zur oralen verabreichung sowie verfahren zu deren herstellung durch gefriertrocknen einer oel-in-wasser-emulsion.
DE69802005D1 (de) Kombination aus prolaminen und polaren pflanzlichen lipiden, verfahren zu deren herstellung sowie deren verwendungen
NO175240C (no) Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
AU1887999A (en) Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
ZA961898B (en) Novel melatonin-antagonist beta-carboline derivatives and analogues thereof containing naphthalenic structure process for their preparation and their medicinal products
IL82231A0 (en) 1-hydroxy-2-pyridones,process for their preparation,and pharmaceutical compositions which contain them and intermediates formed in the preparation of the 1-hydroxy-2-pyridones
DZ2414A1 (fr) 2-amino-6-(2-substitué-4-phenoxy)substituté-pyridines procédé pour leur préparation et compositions pharmaceutiques les contenant.
IL94278A0 (en) 2-saccharine derivatives,their preparation and pharmaceutical compositions containing them
IL83357A (en) Renin-inhibiting peptides, process for their preparation, pharmaceutical compositions containing them, and their use
IL109163A (en) Yeast formulation for the preparation of baked products
DE3767998D1 (de) Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
BR9508034A (pt) Processo e aparelhagem para a preparação de uma unidade comestível que se dissolve rapidamente a referida unidade composição para liberar um ingrediente ativo processo para administração de um ingrediente ativo a um hospedeiro humano e produto provisório para fabricação da unidade comestível
HUT40677A (en) Process for preparing water-soluble platinum compounds and pharmaceutical preparations comprising these compounds as active substance
AU5212093A (en) Dihydro - and tetrahydro-isoquinolines, process for their preparation and pharmaceutical compositions containing same
ZA848141B (en) New cyclic benzensulfonamides,process for their preparation and their use as active substance of pharmaceutical compositions
FI960316A7 (fi) Oksatiolaanit, menetelmä niiden valmistamiseksi ja niitä sisältävät fa rmaseuttiset koostumukset
DE3768084D1 (de) Rekonstituiertes nahrungsmittel, verfahren und mischer zu seiner herstellung.
FR2763592B1 (fr) Nouveaux derives glycosyles des ginkgolides, leur application en tant que medicaments et compositions pharmaceutiques les contenant
DK0740547T3 (da) Liposomer indeholdende deri indkapslede proteiner, fremgangsmåde til deres fremstilling, samt farmaceutiske og kosmetiske p
AU6551198A (en) Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
HUT44764A (en) Process for producing new sulfonamidoethyl derivatives and pharmaceutical preparations comprising them as active substance

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application